Ameritas Investment Partners’s Outset Medical OM Stock Holding History

Ameritas Investment Partners’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,809	Closed	-$6.95K	–	3287
2026 Q1	$6.95K	Hold	1,809	–	–	﹤0.01%	2933
2025 Q4	$6.71K	Hold	1,809	–	–	﹤0.01%	2991
2025 Q3	$25.5K	Hold	1,809	–	–	﹤0.01%	2557
2025 Q2	$34.8K	Buy	+1,809	New	+$28.2K	﹤0.01%	2395
2024 Q2	–	Sell	-327	Closed	-$10.9K	–	3200
2024 Q1	$10.9K	Hold	327	–	–	﹤0.01%	2794
2023 Q4	$26.6K	Hold	327	–	–	﹤0.01%	2457
2023 Q3	$53.4K	Buy	327 +55	+20%	+$13K	﹤0.01%	2065
2023 Q2	$89.3K	Buy	272 +33	+14%	+$10.1K	﹤0.01%	1675
2023 Q1	$66K	Hold	239	–	–	﹤0.01%	1804
2022 Q4	$97.6K	Hold	239	–	–	﹤0.01%	1617
2022 Q3	$57K	Hold	239	–	–	﹤0.01%	1881
2022 Q2	$53K	Hold	239	–	–	﹤0.01%	1953
2022 Q1	$163K	Hold	239	–	–	0.01%	1309
2021 Q4	$165K	Hold	239	–	–	0.01%	1354
2021 Q3	$177K	Hold	239	–	–	0.01%	1305
2021 Q2	$179K	Buy	239 +183	+327%	+$140K	0.01%	1330
2021 Q1	$45K	Hold	56	–	–	﹤0.01%	2145
2020 Q4	$47K	Buy	+56	New	+$43.2K	﹤0.01%	2023

Other funds holding OM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Ameritas Investment Partners's OM Position: Q2 2026 in Review

Ameritas Investment Partners sold out of Outset Medical (OM) in Q2 2026, closing a stake of 1,809 shares — an estimated $6.95K sold.

Ameritas Investment Partners first reported a position in OM in Q4 2020 and held it in 18 quarters. The position peaked at $179K in Q2 2021. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

Ameritas Investment Partners reported no remaining Outset Medical position as of Q2 2026 after selling out during the quarter.
Ameritas Investment Partners sold 1,809 Outset Medical shares in Q2 2026, an estimated $6.95K.
Ameritas Investment Partners first reported a position in Outset Medical in Q4 2020 and held it in 18 quarters.
Ameritas Investment Partners's Outset Medical position peaked at $179K in Q2 2021.
93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.